These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 9295329

  • 41. A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition.
    Hansen M, Wind T, Blouse GE, Christensen A, Petersen HH, Kjelgaard S, Mathiasen L, Holtet TL, Andreasen PA.
    J Biol Chem; 2005 Nov 18; 280(46):38424-37. PubMed ID: 16141208
    [Abstract] [Full Text] [Related]

  • 42. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
    List K, Jensen ON, Bugge TH, Lund LR, Ploug M, Danø K, Behrendt N.
    Biochemistry; 2000 Jan 25; 39(3):508-15. PubMed ID: 10642175
    [Abstract] [Full Text] [Related]

  • 43. Mutations affecting the activity of urokinase-type plasminogen activator.
    Davidow LS, Dumais DR, Smyth AP, Greer J, Moir DT.
    Protein Eng; 1991 Dec 25; 4(8):923-8. PubMed ID: 1817254
    [Abstract] [Full Text] [Related]

  • 44. A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization.
    Egelund R, Einholm AP, Pedersen KE, Nielsen RW, Christensen A, Deinum J, Andreasen PA.
    J Biol Chem; 2001 Apr 20; 276(16):13077-86. PubMed ID: 11278457
    [Abstract] [Full Text] [Related]

  • 45. Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator.
    Kromann-Hansen T, Louise Lange E, Peter Sørensen H, Hassanzadeh-Ghassabeh G, Huang M, Jensen JK, Muyldermans S, Declerck PJ, Komives EA, Andreasen PA.
    Sci Rep; 2017 Jun 13; 7(1):3385. PubMed ID: 28611361
    [Abstract] [Full Text] [Related]

  • 46. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates.
    Takeuchi T, Harris JL, Huang W, Yan KW, Coughlin SR, Craik CS.
    J Biol Chem; 2000 Aug 25; 275(34):26333-42. PubMed ID: 10831593
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR, De Cock F, Collen D.
    Eur J Biochem; 1994 Sep 01; 224(2):567-74. PubMed ID: 7925373
    [Abstract] [Full Text] [Related]

  • 49. Distinguishing the specificities of closely related proteases. Role of P3 in substrate and inhibitor discrimination between tissue-type plasminogen activator and urokinase.
    Ke SH, Coombs GS, Tachias K, Navre M, Corey DR, Madison EL.
    J Biol Chem; 1997 Jun 27; 272(26):16603-9. PubMed ID: 9195973
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator.
    Kirchheimer JC, Resch I, Christ G, Wojta J, Binder BR.
    Eur J Biochem; 1987 Jul 15; 166(2):393-7. PubMed ID: 3609016
    [Abstract] [Full Text] [Related]

  • 55. Regulation of single chain urokinase binding, internalization, and degradation by a plasminogen activator inhibitor 1-derived peptide.
    Zhang L, Strickland DK, Cines DB, Higazi AA.
    J Biol Chem; 1997 Oct 24; 272(43):27053-7. PubMed ID: 9341144
    [Abstract] [Full Text] [Related]

  • 56. Activation of pro-urokinase by plasmin: non-Michaelian kinetics indicates a mechanism of negative cooperativity.
    Scully MF, Ellis V, Watahiki Y, Kakkar VV.
    Arch Biochem Biophys; 1989 Feb 01; 268(2):438-46. PubMed ID: 2521553
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. The Light Chain Allosterically Enhances the Protease Activity of Murine Urokinase-Type Plasminogen Activator.
    Torres-Paris C, Song HJ, Engelberger F, Ramírez-Sarmiento CA, Komives EA.
    Biochemistry; 2024 Jun 04; 63(11):1434-1444. PubMed ID: 38780522
    [Abstract] [Full Text] [Related]

  • 60. Localization of epitopes for monoclonal antibodies to urokinase-type plasminogen activator: relationship between epitope localization and effects of antibodies on molecular interactions of the enzyme.
    Petersen HH, Hansen M, Schousboe SL, Andreasen PA.
    Eur J Biochem; 2001 Aug 04; 268(16):4430-9. PubMed ID: 11502203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.